Meeting
2022 ASCO Annual Meeting
Real-world utilization and comparative effectiveness of treatment options in cancer-associated thrombosis: A propensity score weighed analysis.
Authors
Irbaz Bin Riaz
Mayo Clinic, Phoenix, AZ
Irbaz Bin Riaz , Harry E. Fuentes Bayne , Yihong Deng , Syed Arsalan Ahmed Naqvi , Xiaoxi Yao , Lindsey R. Sangaralingham , Damon E Houghton , Waldemar Wysokinski , Robert McBane
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Real-World Data/Outcomes
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 6589)
DOI
10.1200/JCO.2022.40.16_suppl.6589
Abstract #
6589
Poster Bd #
370
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
The comparative effectiveness of direct oral anti-coagulants and low molecular weight heparins for prevention of recurrent venous thromboembolism in cancer: The CANVAS pragmatic randomized trial.
First Author: Deborah Schrag
Poster
2019 Gastrointestinal Cancers Symposium
An analysis of the safety and efficacy of rivaroxaban (Riv) and low molecular weight heparin (LMWH) in gastrointestinal cancer-associated venous thromboembolism (GICA-VTE).
First Author: Alejandro Recio Boiles
Poster
2018 Gastrointestinal Cancers Symposium
An analysis of the efficacy and safety of direct oral anticoagulants (DOACs) in gastrointestinal cancer-associated venous thromboembolism (GI-CAVTE).
First Author: Alejandro Recio Boiles
Poster
2016 Palliative and Supportive Care in Oncology Symposium
Practice patterns and outcomes of rivaroxaban usage in patients with cancer.
First Author: Carmelita P. Escalante